Editors' Pick Practices of US health insurance companies concerning MS therapies interfere with shared decision-making and harm patients. Bourdette DN, Hartung DM, Whitham RH Neurol Clin Pract. 2016 Apr; 6(2):177-182. Epub 1969 Dec 31. PMID: 27104069. Abstract CommentRecommendBookmarkWatch
